Former Novo Nordisk CSO Marcus Schindler shares insights on pharma R&D, scientific innovation, AI integration and global talent development...
Continue readingSeptember 9, 2025 • by Michael R. Wade, Amit M. Joshi in Pharmaceuticals • 1 min read • 
Podcast available
Discover how AI will revolutionize healthcare! Mike and Amit are joined by Achim Plueckebaum on the latest edition of the IMD Podcast Network to explore the future of medicine....
The healthcare and pharmaceutical sectors are experiencing radical evolution through artificial intelligence, driving competition, and improving clinical outcomes. IMD's AI Maturity Index highlights effective approaches from industry frontrunners like Bayer, Medtronic, and...
IMD research reveals the top four key attributes of successful companies in the Chinese pharma sector, including their global and local strategies as well as their acquisitions and investment in local companies,...
March 6, 2023 • by Misiek Piskorski in Pharmaceuticals • 6 min read
Life sciences giant Bayer is using the latest technology to drive change in three very distinct areas of its business: agriculture, pharma, and personal healthcare. Training and developing a new breed of...
December 13, 2022 • by Howard H. Yu in Pharmaceuticals • 8 min read
The uncertain economic landscape makes predicting winners and losers over the coming year more unpredictable than ever. But Howard Yu and his team focus on hard data to predict what it will...
Audio available
March 24, 2022 • by Corinne Post, Kaitlin Wowak, George Ball, David J. Ketchen Jr in Pharmaceuticals • 6 min read
Pharmaceutical products with the most serious defects are recalled 28 days sooner with women in the boardroom, research shows....
Explore first person business intelligence from top minds curated for a global executive audience
Share
YouTube